MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment On March 12, 2024, Mangoceuticals, Inc. unveiled a groundbre...
Medtronic Received CE Mark for its Next Generation Micra Leadless Pacing Systems On January 5, 2024, Medtronic announced that the Micra AV2 and Micra VR2, the next generation of its industry-leading tiny, leadless pacemakers, earned the CE (Conformité Européenne) Mark. The world's tiniest pacemakers, the rMic...
Find MoreRehabilitation equipment, a cornerstone in the realm of healthcare, has undergone a remarkable evolution over the years, propelled by the rising demand and their potential to improve patient outcomes and restore quality of life. From rudimentary tools and manual therapies to the present-day sophisticated, technolog...
Find MoreThe Energy-Based Aesthetic Devices market stands at the forefront of the evolving landscape of cosmetic treatments, offering a comprehensive range of solutions for individuals seeking non-invasive and minimally invasive procedures to enhance their appearance. Over the past few years, intense advancements in technol...
Find MoreIt is not surprising that the healthcare sector is undergoing a significant transition in an era characterized by technological developments and the digitization of almost every aspect of our lives. The development of smart medical devices is a shining illustration of how technology has advanced in healthcare in a ...
Find MoreThe role and application of Artificial Intelligence have grown at an immense pace in recent years. Globally, several companies including large & small scale businesses, education, retail, and telecommunications, among others are actively exploring opportunities to leverage the potential of AI in their organizat...
Find MoreProstate cancer is the third most frequent cancer in the United States and the fourth most common worldwide. 1 in every 9 males in the United States will be diagnosed with Prostate Cancer at some time in their life. According to the American Cancer Society, Prostate Cancer is the second largest cause of cancer mort...
Find MoreFDA approves IND application of Accutar for a prostate cancer treatment trial The US Food and Drug Administration (FDA) has granted Accutar Biotechnology’s Investigational New Drug (IND) application for Phase I clinical trial of AC0176 for treating metastatic castration-resistant prostate cancer (mCRPC). An i...
Find MoreBenign prostatic hyperplasia, also called Benign prostatic hypertrophy or Benign prostatic obstruction, is a common condition in men as they get older. The prostate gland is a walnut-shaped gland present in men's reproductive systems, and its primary purpose is to produce a fluid that is secreted into semen. The pr...
Find MoreBone tumors are uncommon in adults, however, are a frequent cause of neoplastic diseases among children and the younger population. Primary malignant bone tumors account for approximately 6% of all childhood malignancies with Ewing’s sarcomas as the second most frequently occurring primary malignant bone tumors in ...
Find MoreIt was assumed initially that Alzheimer’s Disease was a rare condition, but now it is considered t.....
Find MoreWearable technology has been gaining momentum for the last few years as an effect of the fourth indu.....
Find MoreRaynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused b.....
Find MoreAn inherited disorder, Von Hippel-Lindau (VHL) syndrome is characterized by the formation of tumors .....
Find MoreThe first biosimilar was made available to patients in the United States six years ago in 2021. Thes.....
Find MoreDigital health technologies can fill the current gaps in oncology care while rebalancing the existin.....
Find MoreLive Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!